[
  {
    "ts": null,
    "headline": "Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals",
    "summary": "If you are wondering whether Hologic's share price still offers value or if most of the opportunity is already priced in, you are exactly who this breakdown is written for. The stock recently closed at US$74.98, with returns of 0.1% over the last week, 0.0% over the last month, 0.6% year to date and 7.5% over the past year, while the 3 year and 5 year returns sit at a 5.9% decline and 1.0% decline respectively. Recent company news has focused on Hologic's position in medical technology and...",
    "url": "https://finnhub.io/api/news?id=846b2f251ffd9e4822d4a0a769f1cb730614d57e537992ec2509f8f1e171c707",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768734455,
      "headline": "Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals",
      "id": 138168562,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "If you are wondering whether Hologic's share price still offers value or if most of the opportunity is already priced in, you are exactly who this breakdown is written for. The stock recently closed at US$74.98, with returns of 0.1% over the last week, 0.0% over the last month, 0.6% year to date and 7.5% over the past year, while the 3 year and 5 year returns sit at a 5.9% decline and 1.0% decline respectively. Recent company news has focused on Hologic's position in medical technology and...",
      "url": "https://finnhub.io/api/news?id=846b2f251ffd9e4822d4a0a769f1cb730614d57e537992ec2509f8f1e171c707"
    }
  }
]